Australia’s National Blood Cancer Taskforce meets for first time | Leukaemia Foundation

Australia’s National Blood Cancer Taskforce meets for first time

Monday September 30 2019

The Leukaemia Foundation established the Blood Cancer Taskforce with the support of the Federal Government to develop Australia’s first National Strategic Action Plan for Blood Cancer.

Co-chaired by Bill Petch (CEO, Leukaemia Foundation) and Professor John Seymour (Director of Cancer Medicine, Clinical Research and Haematology, Peter MacCallum Centre), the Taskforce unites Australia’s leading haematologists, researchers, patients and members of the blood cancer ecosystem for the first time. Their role is to provide a blueprint to help tackle the key issues facing the blood cancer community today and into the future.

The formation of the Taskforce and development of the Plan mark a major milestone for the blood cancer community and will set the national agenda around blood cancer for many years to come.

They met for the first time on 30 September 2019, giving them the opportunity to discuss and agree on how they will achieve the publication and distribution of the National Strategic Action Plan for Blood Cancer Plan by June 2020.

The first step will see the formation of Working Groups led by members of the Taskforce to focus on key priorities identified in the State of the Nation: Blood Cancer in Australia report. These Working Groups will engage in consultation with key blood cancer stakeholders, review existing services, programs and literature, and commence the early stages of drafting the National Strategic Action Plan for Blood Cancer.

The members of the first National Blood Cancer Taskforce are:

Name Position Affiliation
Professor Sanchia Aranda AM CEO Cancer Council Australia
Dr Sharon Avery Haematologist Cairns Base Hospital
Dr John Bashford Director of Research Icon Group & PCPA
A/Professor Kate Burbury Consultant Haematologist;

Deputy Chief Medical Officer

Peter MacCallum Cancer Centre
Dr Joe Collins Representative Lions Club International
Dr Michael Dickinson Haematologist and Disease Group Lead Aggressive Lymphoma (Peter MacCallum) Lymphoma Australia, Chair Medical Subcommittee
Dr Chris Fraser Chair Executive Council ANZCHOG
Professor Maher Gandhi CEO and Director of Clinical Research Mater Research
Professor David Gottlieb Program Director BMT, Head Cell Therapies Westmead Hospital
Barbie Hartigan Advocate Leukaemia Foundation Patient Support
Professor Tim Hughes Cancer Theme Leader SAHMRI
Dr Paul Jackson General Manager Knowledge Management Cancer Australia
Professor David Joske Chairperson Solaris Cancer Care
Melanie Kelly Director Insight Economics
Dr Rishi Kotecha Consultant Paediatric Oncologist & Clinical Haematologist Perth Children’s Hospital; ANZCHOG
A/Professor Steven Lane Head of Cancer Program QIMR Berghofer
Professor Paula Marlton Head of Leukaemia; Deputy Director Haematology Princess Alexandra Hospital
Dr Robert Menz SA&NT Council member RACGP
A/Professor Peter Mollee Director Australasian Leukaemia & Lymphoma Group
Carmel O’Kane Cancer Nurse Practitioner; Vice President & Director Professional Practice Cancer Nurses Society of Australia
Bill Petch CEO Leukaemia Foundation
Professor Miles Prince AM Director of Molecular Oncology and Cancer Immunology Epworth Snowdome Foundation; Myeloma Australia, Epworth Hospital
Professor Andrew Roberts Laboratory Head; Joint Leader, Cancer Research and Treatments Theme Walter and Eliza Hall Institute
Professor John Seymour AM Director: Department of Haematology Peter MacCallum Cancer Centre & Royal Melbourne Hospital
Deborah Sims Patient and advocate Blood Cancer Survivor
Dr Delaine Smith CEO Australasian Leukaemia & Lymphoma Group
Elizabeth de Somer CEO Medicines Australia
Dr Meg Wall Unit Head, Genetics and Molecular Pathology Monash Pathology; Haematology Society of Australia & New Zealand
Dr Will Stevenson Haematologist Royal North Shore Hospital; Haematology Society of Australia & New Zealand
Richard Vines Chairman Rare Cancers Australia
X
X